Supplementary Table 1 and 2 from Potential Role of mTORC2 as a Therapeutic Target in Clear Cell Carcinoma of the Ovary

Supplementary Table 1 and 2 - PDF file 42K, Supplemental Table 1. Phospho-mTOR and Rictor immunoreactivity in CCCs and SACs. Supplemental Table 2. Effects of AZD8055 or RAD001 on cell cycle progression